HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kaifeng Wu Selected Research

lipoate-protein ligase

3/2010Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kaifeng Wu Research Topics

Disease

9Pneumococcal Infections
01/2022 - 03/2010
6Infections
01/2021 - 03/2010
4Pneumonia (Pneumonitis)
01/2021 - 03/2010
3Sepsis (Septicemia)
02/2018 - 03/2010
2Neoplasms (Cancer)
01/2022 - 06/2018
2Body Weight (Weight, Body)
02/2019 - 02/2018
1Leukemia
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Human Influenza (Influenza)
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Coinfection
01/2021
1COVID-19
01/2021
1Adenocarcinoma of Lung
10/2020
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020
1Fibrosis (Cirrhosis)
02/2019
1Malnutrition (Nutritional Deficiencies)
02/2019
1Chronic Obstructive Pulmonary Disease (COPD)
03/2018
1Communicable Diseases (Infectious Diseases)
07/2014

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2010
7VaccinesIBA
01/2021 - 03/2010
4Streptococcus pneumoniae plY proteinIBA
01/2022 - 03/2010
3Polysaccharides (Glycans)IBA
06/2015 - 03/2010
2Toll-Like Receptor 4IBA
01/2022 - 04/2014
2AntigensIBA
02/2018 - 03/2010
2Attenuated VaccinesIBA
01/2015 - 07/2014
1Mannose ReceptorIBA
01/2022
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1EnzymesIBA
01/2021
1ImmunosorbentsIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1SelectinsIBA
01/2021
1ProgranulinsIBA
01/2021
1CytokinesIBA
01/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2021
1Small Interfering RNA (siRNA)IBA
10/2020
14-phenylbutyric acid (Buphenyl)FDA Link
10/2020
1TunicamycinIBA
10/2020
1BilirubinIBA
01/2020
1AntioxidantsIBA
02/2019
1Acute-Phase Proteins (Acute-Phase Protein)IBA
02/2019
118 L1 type 16 human papillomavirus vaccine (Cervarix)IBA
06/2018
1Papillomavirus Vaccines (HPV Vaccines)IBA
06/2018
1Human Papillomavirus Recombinant Vaccine nonavalentIBA
06/2018
1Toll-Like Receptors (Toll-Like Receptor)IBA
03/2018
1Toll-Like Receptor 3IBA
03/2018
1Peptides (Polypeptides)IBA
02/2018
1calcium phosphateIBA
02/2018
1aluminum sulfate (alum)IBA
02/2018
1Penicillins (Penicillin)FDA Link
12/2017
1Capsules (Microcapsules)IBA
01/2016
1Staphylococcal Protein A (Protein A)IBA
06/2015
1AcidsIBA
02/2015
1Interleukin-17 (Interleukin 17)IBA
04/2014
1Recombinant Fusion ProteinsIBA
04/2014
1Ethanol (Ethyl Alcohol)IBA
04/2014
1Conjugate VaccinesIBA
04/2014
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
04/2014
1Cholera ToxinIBA
04/2014
1Peptide Hydrolases (Proteases)FDA Link
03/2010
1Adenosine Triphosphate (ATP)IBA
03/2010
1lipoate-protein ligaseIBA
03/2010

Therapy/Procedure

1Therapeutics
01/2022
1Subcutaneous Injections
02/2018